THERAPY SYSTEMS AND METHODS UTILIZING TISSUE OXYGENATION DETECTION

• US 20150217056A1
• Filed: 12/29/2014
• Published: 08/06/2015
• Est. Priority Date: 12/31/2013
• Status: Abandoned Application

• Current Assignee: Stratos Group LLC
• Original Assignee: Stratos Group LLC
• Inventors: Stephan, Allan H., Kadavy, Thomas Daniel
• Application Number:
  US14/584,767
• Publication Number:
  US 20150217056A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61H 31/006 Power driven
• CPC Class Codes: A61M 16/10 Preparation of respiratory gases or vapours
• CPC Class Codes: A61M 2202/0208 Oxygen
• CPC Class Codes: A61M 2205/3303 Using a biosensor
• CPC Class Codes: A61M 2230/205 partial oxygen pressure (P-O2)
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

Systems for controlling or aiding patient therapy are provided. The systems may include a tissue oxygenation measurement device and a therapy delivery apparatus that is controllable to assist in attaining a target tissue oxygenation level or range, whereby patient health is improved by optimizing delivery of therapy based on measured tissue oxygenation. The therapy delivery apparatus may include, for example, a drug delivery apparatus, a ventilating apparatus, a fluid delivery apparatus and/or a chest compression delivery apparatus. The tissue oxygenation measurement device may include a probe for determining the oxygenation of tissue, for example, muscle tissue, by optically interrogating the tissue. Related methods for guiding patient therapy and exercise training are also provided.

Claims

1. A method for guiding patient therapy, the method comprising:

measuring an oxygenation level of a patient'"'"'s tissue using the following ratio;

2. The method of claim 1 wherein adjusting delivery of the pharmaceutical drug to the patient via the drug delivery apparatus includes delivering a dosage of the pharmaceutical drug in response to a decrease in the measured ratio beyond a first threshold value.

3. The method of claim 2 wherein adjusting delivery of the pharmaceutical drug to the patient via the drug delivery apparatus includes delivering a supplemental dosage of the pharmaceutical drug in response to a subsequent decrease in the measured ratio beyond the first threshold value.

4. The method of claim 1 wherein adjusting delivery of the pharmaceutical drug to the patient via the drug delivery apparatus includes delivering the pharmaceutical drug based at least in part on a trend of the measured ratio over time.

5. A system for guiding patient therapy, the system comprising:

a probe for detecting in vivo tissue oxygenation in a patient;

a drug delivery apparatus; and

a controller coupled to the probe and the drug delivery apparatus, the controller configured to measure an oxygenation level of the patient'"'"'s tissue using the probe and the following ratio;

oxymyoglobin+oxyhemoglobin

(deoxymyoglobin+deoxyhemoglobin)+(oxymyoglobin+oxyhemoglobin), and to adjust delivery of a pharmaceutical drug to the patient via the drug delivery apparatus based at least in part on said ratio, whereby the patient'"'"'s tissue oxygenation is modified toward a target level.

6-21. -21. (canceled)

22. A system for guiding therapy of a patient in shock, the system comprising:

a probe for detecting in vivo tissue oxygenation in a patient;

a fluid delivery apparatus;

a ventilating apparatus;

a drug delivery apparatus; and

a controller coupled to the probe, the fluid delivery apparatus, the ventilating apparatus and the drug delivery apparatus, the controller configured to measure an oxygenation level of the patient'"'"'s tissue using the probe and the following ratio;

oxymyoglobin+oxyhemoglobin

(deoxymyoglobin+deoxyhemoglobin)+(oxymyoglobin+oxyhemoglobin), and to adjust delivery of intravenous fluid, oxygen and a pharmaceutical drug to the patient using the fluid delivery apparatus, the ventilating apparatus and the drug delivery apparatus, respectively, whereby the patient'"'"'s tissue oxygenation is modified toward a target level.

23. A system for controlling or aiding patient therapy, the system comprising:

a tissue oxygenation measurement device; and

a therapy delivery apparatus that is controllable to assist in attaining a target tissue oxygenation level or range, whereby patient health is improved by optimizing delivery of therapy based on measured tissue oxygenation.

24. The system of claim 23 wherein the therapy delivery apparatus is configured to provide chest compressions for purposes of cardio pulmonary resuscitation.

25. The device of claim 23 wherein the therapy delivery apparatus provides pharmaceutical drugs.

26. The system of claim 23 wherein the therapy delivery apparatus provides intravenous fluids.

27. The system of claim 23 wherein the therapy delivery apparatus provides oxygen gas.

28. The system of claim 23 wherein the therapy delivery apparatus provides oxygen gas and air.

29-41. -41. (canceled)